Volume : 10, Issue : 03, March – 2023
Title:
47.ANALYTICAL METHOD VALIDATION REPORT FOR ASSAY OF TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE AND ISONIAZID BY RP-HPLC
Authors :
H.padmalatha
Abstract :
A New method was established for simultaneous estimation of Emtricitabine, Tenofovir disoproxil fumarate and Isoniazid by RP-HPLC method. proposed analytical methods are simple, novel, economical, rapid, sensitive, reproducible and accurate for the Simultaneous estimation of Tenofovir Disoproxil Fumarate, Emtricitabine and Isoniazid in Bulk and Phamaceutical dosage form by using RP-HPLC. This Method gives reliable assay results with short analysis time using mobile phase of Acetonitrile: 0.02M Potassium Dihydrogen Orthophosphate: water (pH 5.3) in the ratio of 60: 25: 15 respectively. Retention time was found to be 2.3 min, 3.7min and 4.9 min for Tenofovir Disoproxil Fumarate, Emtricitabine and Isoniazid respectively. System suitability parameters were in the desired Limit. This method has been developed and optimized as per ICH Q2 (R1) guidelines.
Keywords: Emtricitabine, Tenofovir disoproxil fumarate and Isoniazid, RP‐HPLC, Simultaneous estimation.
Cite This Article:
Please cite this article in press H.padmalatha, Analytical Method Validation Report For Assay Of Tenofovir Disoproxil Fumarate, Emtricitabine And Isoniazid By RP-HPLC., Indo Am. J. P. Sci, 2023; 10 (03).
Number of Downloads : 10
References:
1. Storch CH, Theile D, Lindenmaier H, Haefeli WE, Weiss J: Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochem Pharmacol. 2007 May 15;73(10):1573-81.
2. Soriano V, Labarga P, Fernandez-Montero JV, Mendoza C, Benitez-Gutierrez L, Pena JM, Barreiro P: Drug interactions in HIV-infected patients treated for hepatitis C. Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):807-816.
3. FDA Approved Drug Products: Emtriva (Emtricitabine) Oral Capsules
4. FDA Press Announcements: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic.
5. Pym AS, Domenech P, Honore N, Song J, Deretic V, Cole ST: Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol Microbiol. 2001 May;40(4):879-89. [Article]
6. Heym B, Alzari PM, Honore N, Cole ST: Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol. 1995 Jan;15(2):235-45. [Article]
7. Wilson TM, de Lisle GW, Collins DM: Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol. 1995 Mar;15(6):1009-15. [Article]
8. Vilcheze C, Jacobs WR Jr: The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol. 2007;61:35-50. [Article]
9. MD Abdul Sattar* and Suneetha Achanta. Analytical Method Development and Validation for the Determination of Emtricitabine and Tenofovir Disoproxil Fumarate Using Reverse Phase HPLC Method in Bulk and Tablet Dosage Form. /J. Pharm. Sci. & Res. Vol. 10(5), 2018, 1207-1212
10. Shah A.U., Kotadiya V. V., Ajmera A. A. Department of Quality Assurance, K.B. Raval College Pharmacy, Gandhinagar-382423, India. Research J. Pharm. and Tech. 2016; 9(4): 463-468.
11. Ramaswamy, Anton Smith Arul Gnana Dhas, Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLC, Arabian Journal of Chemistry,2018,11(2),275-281
12. Tej Kumar Kokkirala & Duvvuri Suryakala (2019) RP-HPLC method development and validation for the estimation of Emtricitabine, Bictegravir and Tenofovir alafenamide in bulk and pharmaceutical dosage form, Journal of Taibah University for Science, 13:1, 1137-1146.
13. Rao BV, Vidyadhara S, Nagaraju B and Jhonbi SK: A novel stability indicating RP-HPLC method development and validation for the determination of tenofovir disoproxil fumarate and emtricitabine in bulk and pharmaceutical formulations. Int J Pharm Sci Res 2017; 8(5): 2168-76
14. Reddy BRY, Reddy MT, Reddy BSC (2015) Simultaneous Estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in Tablet Dosage Form by Reverse Phase High-performance Liquid Chromatography. SOJ Chromatograph Sci 1(1): 6.
15. Sharma R, Gupta P. A Validated RP – HPLC Method for Simulataneous Estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in a Tablet Dosage Form. Eurasian Journal of Analytical Chemistry. 2009;4(3):276-284.
16. Prasanthi B, Vijaya ratnar. S, Phani Ch. Development and validation of RP-HPLC method for simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma. J of Anal Chem.2015; 70(8):1015-1022.
17. Khuhawar M.Y, F. M. A. Rind, and A. D. Rajper. High-performance liquid chromatographic determination of isoniazid, pyrazinamide, and indomethacin in pharmaceutical preparations. Acta chromatographica. 2005; 15:205-207.
18. S.K. Dhal and R. Sharma. Development and Validation of RP-HPLC Method for Simultaneous Determination of Pyridoxine Hydrochloride, Isoniazid, Pyrazinamide and Rifampicin in pharmaceutical Formulation. Chem. Anal. (Warsaw).2009; 54:1487.
19. Rohit Bhandari and Indu Pal Kaur, A Sensitive HPLC Method for Determination of Isoniazid in Rat Plasma, Brain, Liver and Kidney Chromatography Separation Techniques.J Chromat Separation Techniq. 2012; 3:3-7.
20. Suchada Jongrungruangchok, Thanapat Songsak. Validation of HPLC methods for determination of isoniazid, rifampicin, pyrazinamide, and ethambutol in fixed-dose combination antituberculosis. Bulletin of Health, Science and Technology.2015; 13(1): 17-28.
21. O. E Bouazzi, N. Badrane, F. Zalagh, R. Soulaymani Bencheikh, Bengueddour R. and L. Ait Moussa. Optimization and validation of rapid and simple method for determination of Isoniazid and Pyrazinamide in plasma by HPLC-UV. Journal of Chem and PharmaRes. 2016; 8(3):165- 169.
22. L.Ait Moussa, C. Khassouani, R.Soulaymani, M.Jana, G.Cassanas and R.Alric, et al. Therapeutic isoniazid monitoring using a simple high performance liquid chromatographic method with ultraviolet detection. J Chromatogr B 2002b; 766: 181–187.